Five public offerings in less than two weeks places 2004 more than a month ahead of last year in terms of follow-on funds raised. The two newest offerings on Tuesday benefited Antigenics Inc., which raised $52.5 million, and Onyx Pharmaceuticals Inc., which raised $156.5 million. (BioWorld Today) Read More